CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Phathom Pharmaceuticals Completes Patient Enrollment for Phase 2 Trial of Voquezna

Phase 2VoqueznaPositive
AI Analysis

Summary

Phathom Pharmaceuticals has completed patient enrollment for a Phase 2 trial of its drug Voquezna. No clinical outcome data or specific patient numbers were disclosed in this announcement.

Clinical Trial Data

Phase

Phase 2

Importance:5/10
Sentiment:
0.50
clinical_trialpatient_enrollmentPhase_2
Related Companies

Read the original article

Published by yahoo_finance on June 23, 2026 12:26 PM

Read Original